|Bid||6.36 x 0|
|Ask||6.44 x 0|
|Day's Range||6.09 - 6.69|
|52 Week Range||2.65 - 10.05|
|Beta (5Y Monthly)||2.06|
|PE Ratio (TTM)||54.83|
|Earnings Date||Jul. 30, 2020 - Aug. 04, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.19|
Aphria (APHA) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
TORONTO — Some of the most active companies traded Monday on the Toronto Stock Exchange:Toronto Stock Exchange (15,639.41, down 74.41 points.)The Toronto-Dominion Bank (TSX:TD). Financials. Up 84 cents, or 1.4 per cent, to $60.76 on 9 million shares.B2Gold Corp. (TSX:BTO). Materials. Down 21 cents, or 2.6 per cent, to $7.86 on 8.2 million shares.Enbridge Inc. (TSX:ENB). Energy. Up 24 cents, or 0.6 per cent, to $40.39 on 7.4 million shares.Canadian Natural Resources Ltd. (TSX:CNQ). Energy. Up 14 cents, or 0.61 per cent, to $23.05 on 7.3 million shares.Suncor Energy Inc. (TSX:SU). Energy. Up 15 cents, or 0.68 per cent, to $22.10 on 6.2 million shares.Aphria Inc. (TSX:APHA). Health care. Up 52 cents, or 8.92 per cent, to $6.35 on 6 million shares.Companies in the news:Pieridae Energy Ltd. (TSX:PEA). Down one cent or 2.9 per cent to 33.5 cents. Pieridae Energy Ltd. says the engineering company it hired to build its proposed Goldboro LNG export facility in Nova Scotia is withdrawing from an agreement to provide a fixed price contract for the job. The Calgary-based company says it has received written notice from Kellogg Brown & Root Ltd. that it is no longer prepared to enter into a lump-sum turnkey engineering, procurement, construction and commissioning contract for the project as agreed in March 2019, although it is willing to provide the services on other terms. Pieridae CEO Alfred Sorensen says the company is considering options including legal action in response, but has already had discussions with other firms willing to replace KBR. In May, Pieridae announced a delay in making a final decision on proceeding with the project to export liquefied natural gas from Canada's East Coast, citing technical obstacles created by COVID-19.Intertape Polymer Group Inc. (TSX:ITP). Up 60 cents or 4.7 per cent to $13.29. Intertape Polymer Group Inc. says its second-quarter revenue was substantially above its expectations due to strong demand as customers resumed activity following their COVID closures. According to Intertape's preliminary estimate, revenue for the three months ended June 30 was US$267 million — 6.8 per cent above the high end of its May 13 estimate. It says the result implies that its adjusted earnings will also best the top end of its estimate range. The company manufacturers a variety of products used for packaging, including tapes and films. The company had experienced a 10 per cent year-over-year decline in sales over the first part of the quarter to May 8 because of the COVID slowdown. Intertape withdrew its full-year guidance in May because of the uncertain environment, but estimated it would have between US$235 million and US$250 million of revenue in the second quarter. Yamana Gold Inc. (TSX:YRI). Down 28 cents or 3.7 per cent to $7.21. Yamana Gold Inc. says the Canadian Malartic mine in Quebec has ramped up production more quickly than anticipated following a COVID-related shut-down. The mine, one of North America's largest gold producers, milled more than 60,000 tonnes per day of ore in both May and June, partially offsetting the down time and ramp-up in production that began April 15 after the province allowed work to resume. Yamana estimates its total gold production for the second quarter was 164,141 ounces, including Canadian Malartic and its four South American mines. Silver production was estimated at about two million ounces. Yamana says all of the mines exceeded planned production targets in the second quarter and it continues to expect more production, improved costs and significant cash flows in the second half of 2020. The Toronto-based company has a 50 per cent ownership stake in Canadian Malartic, with the other half owned by Agnico Eagle Mines Ltd.This report by The Canadian Press was first published July 13, 2020.The Canadian Press
What happened Shares of Aphria (NASDAQ: APHA) climbed 8.8% on Monday, following an analyst upgrade of the marijuana stock. So what Stifel analyst W. Andrew Carter lifted his rating on Aphria's stock to buy from hold and placed a $5.
Here's why you can look to buy Aphria Inc (TSX:APHA)(NASDAQ:APHA) stock instead of Canopy Growth (TSX:WEED)(NYSE:CGC) stock.The post Buy This 1 Weed Stock Instead of Canopy Growth (TSX:WEED) Stock appeared first on The Motley Fool Canada.
As a result of the COVID-19 pandemic, marijuana sales are skyrocketing as many people are turning to the product to deal with isolation, anxiety, and depression. Indeed, new market research compiled by Marijuana Business Factbook estimates medical and recreational cannabis sales are on track to grow by 40% this year over 2019, bringing total annual revenue to $15 billion by the end of 2020. Furthermore, the U.S. marijuana sector alone is estimated to be worth $37 billion by 2024 as more states join the legalization bandwagon.
LEAMINGTON, ON, July 6, 2020 /CNW/ - Aphria Inc. (" Aphria ") (TSX: APHA and NASDAQ: APHA), a leading global cannabis company, today announced that it has issued 1,658,375 common shares (the ...
Today, I'll look at two of the top pot stocks in the industry -- Aphria (NASDAQ: APHA) and Canopy Growth (NYSE: CGC) -- and assess which of these leading cannabis producers is the better stock to hold in your portfolio. One of the ways Aphria has established itself as one of the safer stocks in the industry is by being able to stay in the black on a relatively consistent basis. In its most recent quarterly results, which the company released on April 14, Aphria posted a net income of 5.7 million Canadian dollars on net revenue of CA$144.4 million.
Here's why cannabis investors should buy profitable stocks such as Aphria (TSX:APHA) and OrganiGram (TSX:OGI) right now. The post Ranking 3 Top Marijuana Stocks for 2020 appeared first on The Motley Fool Canada.
If you are looking to gain exposure to the marijuana space, look no further than Aphria (TSX:APHA) stock. The post Why Is Aphria (TSX:APHA) the Ultimate Pot Stock? appeared first on The Motley Fool Canada.
LEAMINGTON, ON, June 25, 2020 /CNW/ - Aphria Inc. ("Aphria") (TSX: APHA and NASDAQ: APHA), a leading global cannabis company, Emblem Cannabis Corporation ("Emblem"), and Aleafia Health Inc. (TSX: AH, OTC: ALEAF) ("Aleafia Health") today announced the parties entered into a settlement agreement on June 25, 2020 (the "Settlement Agreement") to resolve their outstanding dispute in respect of the termination of the parties' wholesale cannabis supply agreement (the "Supply Agreement"). Under the terms of the Settlement Agreement, Emblem shall receive total consideration of C$29,100,000 comprised of a C$15,500,000 cash payment, the issuance of common shares of Aphria with an aggregate market value of C$10,000,000 that will be freely tradeable and transferable in Canada and waiver of claimed receivables.
TSX cannabis stocks are up almost 50% in the last three months. Will the strength continue going forward? Or is weakness in the cards?The post How Top TSX Cannabis Stocks Are Placed for the Future appeared first on The Motley Fool Canada.
The green industry finally saw some green in the past few months. If it still has potential, which player should you bet on, Aphria or Aurora?The post Better Weed Stock: Aphria (TSX:APHA) vs. Aurora (TSX:ACB) appeared first on The Motley Fool Canada.
Today, we'll look at which of the two leading companies in the marijuana sector, Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY), is a better buy right now. During the first quarter of 2020, Tilray recognized $52.1 million in revenue, a rise of 126% year over year. Although that growth is spectacular, the company is not profitable -- it recorded a net loss of $184 million, largely due to non-cash adjustments to the fair value of its warrants.
In most places, the marijuana industry was deemed essential amid widespread lockdowns -- which is why revenue is pouring in for the sector. Then, there are Cronos Group (NASDAQ: CRON) and Aphria (NASDAQ: APHA), which are focused on staying afloat with their strong balance sheets. Its work on producing cannabinoids more cheaply and efficiently through biosynthesis with its partner Ginkgo Bioworks is impressive.